SCHEMBL1998199

SCHEMBL1998199

O=C1CN(Cc2ccc(-c3ccc(F)c(CN4CCS(=O)(=O)CC4)c3)cc2)C(=O)N1C1CCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 3/20 0.50
MCHR1 Q99705 3/20 0.37
KCNH2 Q12809 2/20 0.37
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
JAK1 P23458 3/20 0.35
JAK2 O60674 3/20 0.34
TYK2 P29597 3/20 0.34
GRM2 Q14416 2/20 0.34
HTR2A P28223 1/20 0.34
HTR1A P08908 1/20 0.33
DRD2 P14416 1/20 0.33
CYP2C19 P33261 2/20 0.32
PDE2A O00408 1/20 0.32
STK10 O94804 1/20 0.32
ABL1 P00519 1/20 0.32
CYP1A2 P05177 1/20 0.32
CSF1R P07333 1/20 0.32
FLT1 P17948 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2001798 0.88 ENPP2 (0.51) ENPP2KMT2AMEN1HRH3GRM2
SCHEMBL2000525 0.85 ENPP2 (0.52) ENPP2MCHR1KCNH2KMT2AMEN1
SCHEMBL1998349 0.84 ENPP2 (0.48) ENPP2MCHR1KCNH2HRH3JAK2
SCHEMBL1998874 0.83 MCHR1 (0.35) ENPP2MCHR1KCNH2KMT2AMEN1
SCHEMBL839915 0.83 ENPP2 (0.46) ENPP2MCHR1KCNH2KMT2AMEN1
SCHEMBL2001890 0.81 KMT2A (0.37) ENPP2KMT2AMEN1HRH3GRM2
SCHEMBL1999482 0.81 ENPP2 (0.48) ENPP2MCHR1KCNH2KMT2AMEN1
SCHEMBL838691 0.79 ENPP2 (0.43) ENPP2MCHR1KCNH2KMT2AMEN1
SCHEMBL839140 0.77 ENPP2 (0.47) ENPP2KCNH2KMT2AMEN1JAK1
SCHEMBL2000857 0.75 ENPP2 (0.53) ENPP2KMT2AMEN1HRH3GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960560-B2 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione N.V. ORGANON (NL) 2011-06-14 US claimed
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE N. V. ORGANON 2010-06-10 US claimed
US-7960560-B2 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione N.V. ORGANON (NL) 2011-06-14 US disclosed
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE N. V. ORGANON 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE OPRM1, OR10J3, OPRD1 ENPP2 1556/4885MCHR1 663/4885KCNH2 123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.